RediTrex

Product NDC
66220-812
11-digit product format
662200812
Labeler code
66220
Product ID
66220-812_806b78db-9e7c-4a88-abd2-86a939f95986
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
methotrexate
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
Cumberland Pharmaceuticals Inc.
Application
NDA210737
Marketing category
NDA
Marketing start
2020-07-01
Marketing end
0000-00-00
Substance
METHOTREXATE
Active strength
13 mg/.5mL
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
66220-812-11ML - Milliliter66220-8128bcc2a92-940d-46bd-9f9f-1bc975a34d2e12021-02-05
66220-812-22ML - Milliliter66220-81254cf0117-76bb-4770-a19a-4feeb3ca5f2712021-02-05

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
66220-812-22662200812224 CARTON in 1 CASE (66220-812-22) > 1 SYRINGE in 1 CARTON (66220-812-11) > .5 mL in 1 SYRINGE4 carton2020-07-010000-00-00NoNoCurrent